Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

600521

Rang in Aktien #4352
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Aktienkurs
$2.41
Marktkapitalisierung
$3.61B
Veränderung (1 Tag)
-0.60%
Veränderung (1 Jahr)
-10.36%
Land
CN
Handel Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

Kategorie

Healthcare
Aktien-Split-Historie für Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Die Aktie Zhejiang Huahai Pharmaceutical Co., Ltd. (Symbol: 600521) durchlief insgesamt 11 Aktiensplits.
Der letzte Aktiensplit fand am Jun 08, 2020 statt.
Eine 600521-Aktie, die vor dem Apr 30, 2004 gekauft wurde, entspricht heute 15.497741259 600521-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2020-06-08 11:10 x1.1 x15.497741259
2018-05-25 6:5 x1.2 x14.08885569
2016-06-06 13:10 x1.3 x11.740713075
2013-05-10 203:200 x1.015 x9.03131775
2013-04-17 13:10 x1.3 x8.89785
2011-05-10 6:5 x1.2 x6.8445
2010-05-04 3:2 x1.5 x5.70375
2008-05-13 13:10 x1.3 x3.8025
2005-08-16 5:4 x1.25 x2.925
2005-04-22 13:10 x1.3 x2.34
2004-04-30 9:5 x1.8 x1.8
Aktiensplits ähnlicher Unternehmen oder Wettbewerber